EKF Diagnostics Holdings Plc (LSE:EKF) — Market Cap & Net Worth
Market Cap & Net Worth: EKF Diagnostics Holdings Plc (EKF)
EKF Diagnostics Holdings Plc (LSE:EKF) has a market capitalization of $1.30 Million (GBX10.70 Billion) as of September 24, 2026. Listed on the LSE stock exchange, this UK-based company holds position #30506 globally and #765 in its home market, demonstrating a -3.85% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying EKF Diagnostics Holdings Plc's stock price GBX25.00 by its total outstanding shares 428153112 (428.15 Million). Also see total assets of EKF Diagnostics Holdings Plc for a full breakdown of the balance sheet.
EKF Diagnostics Holdings Plc Market Cap History: 2015 to 2026
EKF Diagnostics Holdings Plc's market capitalization history from 2015 to 2026. Data shows growth from $567.32K to $1.30 Million (2.63% CAGR). Also see EKF cash generation efficiency for how efficiently the company converts equity into cash flow.
Index Memberships
EKF Diagnostics Holdings Plc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
FTSE AIM All Share Index
FTAI
|
$1.02 Billion | 0.13% | #132 of 722 |
Weight: EKF Diagnostics Holdings Plc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
EKF Diagnostics Holdings Plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how EKF Diagnostics Holdings Plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check EKF Diagnostics Holdings Plc share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.03x
EKF Diagnostics Holdings Plc's market cap is 0.03 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.65x
EKF Diagnostics Holdings Plc's market cap is 0.65 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $809.61K | $38.59 Million | -$18.00K | 0.02x | N/A |
| 2017 | $1.24 Million | $41.58 Million | $2.71 Million | 0.03x | 0.46x |
| 2018 | $1.29 Million | $42.54 Million | $10.11 Million | 0.03x | 0.13x |
| 2019 | $1.62 Million | $44.92 Million | $3.68 Million | 0.04x | 0.44x |
| 2020 | $3.44 Million | $65.26 Million | $11.11 Million | 0.05x | 0.31x |
| 2021 | $3.64 Million | $81.84 Million | $15.85 Million | 0.04x | 0.23x |
| 2022 | $2.50 Million | $66.64 Million | -$10.10 Million | 0.04x | N/A |
| 2023 | $1.65 Million | $52.61 Million | $2.35 Million | 0.03x | 0.70x |
| 2024 | $1.41 Million | $50.19 Million | $6.24 Million | 0.03x | 0.23x |
| 2025 | $1.38 Million | $51.56 Million | $2.12 Million | 0.03x | 0.65x |
Competitor Companies of EKF by Market Capitalization
Companies near EKF Diagnostics Holdings Plc in the global market cap rankings as of September 24, 2026. Review EKF Diagnostics Holdings Plc tangible equity quality to assess the quality of the company's equity after excluding intangible assets.
Key companies related to EKF Diagnostics Holdings Plc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #122 globally with a market cap of $180.30 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #237 globally with a market cap of $105.52 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #122 | Abbott Laboratories | NYSE:ABT | $180.30 Billion | $103.69 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $90.77 |
| #237 | Stryker Corporation | NYSE:SYK | $105.52 Billion | $275.09 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
EKF Diagnostics Holdings Plc Historical Marketcap From 2015 to 2026
Between 2015 and today, EKF Diagnostics Holdings Plc's market cap moved from $567.32K to $ 1.30 Million, with a yearly change of 2.63%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | GBX1.30 Million | -5.30% |
| 2025 | GBX1.38 Million | -2.22% |
| 2024 | GBX1.41 Million | -14.69% |
| 2023 | GBX1.65 Million | -33.96% |
| 2022 | GBX2.50 Million | -31.47% |
| 2021 | GBX3.64 Million | +5.93% |
| 2020 | GBX3.44 Million | +112.40% |
| 2019 | GBX1.62 Million | +25.46% |
| 2018 | GBX1.29 Million | +4.00% |
| 2017 | GBX1.24 Million | +53.29% |
| 2016 | GBX809.61K | +42.71% |
| 2015 | GBX567.32K | -- |
End of Day Market Cap According to Different Sources
On Sep 23rd, 2026 the market cap of EKF Diagnostics Holdings Plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.30 Million USD |
| MoneyControl | $1.30 Million USD |
| MarketWatch | $1.30 Million USD |
| marketcap.company | $1.30 Million USD |
| Reuters | $1.30 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About EKF Diagnostics Holdings Plc
EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm analyzer; Hemo Control, a hemoglobin analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit rea… Read more